Zobrazeno 1 - 10
of 176
pro vyhledávání: '"İhsan Ates"'
Autor:
Ferda Can, Tansu Büyükgül, Nuray Yılmaz Cakmak, Ihsan Ates, Vehap Topcu, Said Furkan Yıldırım, Sema Akıncı
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp 3-4 (2024)
Objective: Screening for hereditary thrombophilia is recommended for venous thrombosis, but there is conflicting information about the causal relation with arterial thrombosis. In this study, in order to clarify these conflicting results and recommen
Externí odkaz:
https://doaj.org/article/91811b6b75b34378a17c8d09938bf7bb
Autor:
Zafer Sezer, Shaikh Terkis Islam Pavel, Ahmet Inal, Hazel Yetiskin, Busra Kaplan, Muhammet Ali Uygut, Ahmet Furkan Aslan, Adnan Bayram, Mumtaz Mazicioglu, Gamze Kalin Unuvar, Zeynep Ture Yuce, Gunsu Aydin, Refika Kamuran Kaya, Ihsan Ates, Ates Kara, Aykut Ozdarendeli
Publikováno v:
Vaccines, Vol 12, Iss 2, p 140 (2024)
Vaccine-induced immunity wanes over time and warrants booster doses. We investigated the long-term (32 weeks) immunogenicity and safety of a third, homologous, open-label booster dose of TURKOVAC, administered 12 weeks after completion of the primary
Externí odkaz:
https://doaj.org/article/4c74fde40dfc40e3a45a1fce48df4d77
Autor:
Mine Durusu Tanriover, Ozlem Altuntas Aydin, Rahmet Guner, Orhan Yildiz, Ilhami Celik, Sukran Kose, Sila Akhan, Emin Halis Akalin, Aykut Ozdarendeli, Serhat Unal, Ihsan Ates, Ates Kara
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
This study- a secondary analysis of data from a randomized, observer-blinded, non-inferiority study among volunteers between 18–55 y old in Türkiye- evaluated the impact of previous SARS-CoV-2 infection before the first dose of inactive TURKOVAC o
Externí odkaz:
https://doaj.org/article/99e01bd476994f92ba56843b38725bcf
Autor:
Ihsan Ates, Ayse Batirel, Mehtap Aydin, Fatma Yilmaz Karadag, Abdulsamet Erden, Orhan Kucuksahin, Berkan Armagan, Serdar Can Guven, Ozlem Karakas, Selim Gokdemir, Lutfiye Nilsun Altunal, Aslihan Ayse Buber, Emin Gemcioglu, Oguzhan Zengin, Osman Inan, Enes Seyda Sahiner, Gulay Korukluoglu, Zafer Sezer, Aykut Ozdarendeli, Ahmet Omma, Ates Kara
Publikováno v:
Vaccines, Vol 11, Iss 7, p 1234 (2023)
The immunogenicity of vaccines decreases over time, causing a need for booster doses. This study aimed to present the long-term (Day 84) immunogenicity results of the double-blind, randomized, controlled, phase II Hybrid COV-RAPEL TR Study (NCT049799
Externí odkaz:
https://doaj.org/article/de676a2951d24c999afea7276d33f31e
Autor:
Ishak San, Emin Gemcioglu, Salih Baser, Nuray Yilmaz Cakmak, Abdulsamet Erden, Seval Izdes, Ramis Catalbas, Mehmet Davutoglu, Berkan Karabuga, Ihsan Ates
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract In this study, we compare the predictive value of clinical scoring systems that are already in use in patients with Coronavirus disease 2019 (COVID-19), including the Brescia-COVID Respiratory Severity Scale (BCRSS), Quick SOFA (qSOFA), Sequ
Externí odkaz:
https://doaj.org/article/f3de5fff31834f5f81f9849c11b73dde
Autor:
Rahmet Guner, Bircan Kayaaslan, Imran Hasanoglu, Adalet Aypak, Hurrem Bodur, Ihsan Ates, Esragul Akinci, Deniz Erdem, Fatma Eser, Seval Izdes, Ayse Kaya Kalem, Aliye Bastug, Aysegul Karalezli, Aziz Ahmet Surel, Muge Ayhan, Selma Karaahmetoglu, Isıl Ozkocak Turan, Emine Arguder, Burcu Ozdemir, Mehmet Nevzat Mutlu, Yesim Aybar Bilir, Elif Mukime Sarıcaoglu, Derya Gokcinar, Sibel Gunay, Bedia Dinc, Emin Gemcioglu, Ruveyda Bilmez, Omer Aydos, Dilek Asilturk, Osman Inan, Turan Buzgan
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-13 (2021)
Abstract Background Early identification of severe COVID-19 patients who will need intensive care unit (ICU) follow-up and providing rapid, aggressive supportive care may reduce mortality and provide optimal use of medical resources. We aimed to deve
Externí odkaz:
https://doaj.org/article/6dfd8772b10f42ce86b5f417552f585e
Autor:
Ahmet Omma, Ayse Batirel, Mehtap Aydin, Fatma Yilmaz Karadag, Abdulsamet Erden, Orhan Kucuksahin, Berkan Armagan, Serdar Can Güven, Ozlem Karakas, Selim Gokdemir, Lutfiye Nilsun Altunal, Aslihan Ayse Buber, Emin Gemcioglu, Oguzhan Zengin, Osman Inan, Enes Seyda Sahiner, Gulay Korukluoglu, Zafer Sezer, Aykut Ozdarendeli, Ates Kara, Ihsan Ates
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 6 (2022)
Protective neutralizing antibody titers reduce in time after COVID-19 vaccinations, as in individuals who have had COVID-19. This study aimed to evaluate the safety and immunogenicity of CoronaVac and TURKOVAC vaccines used as a booster dose after Co
Externí odkaz:
https://doaj.org/article/8c21a7499126460eb2a45f3715e4845c
Autor:
Hatice Kilic, Emine Arguder, Aysegul Karalezli, Ebru Unsal, Rahmet Guner, Bircan Kayaslan, İmran Hasanoglu, İhsan Ates, Musa Civak, Esmehan Akpınar, Ebru Parlak, Filiz Sadi, Yasin Kocaman, Sibel Günay, Esra Metan, Mukremin Er, Aynil Dalkıran, Habibe Hezer, Hülya Ergüden, Zeynep Hancıoğlu, Ayşe Kalem, Fatma Eser, Adalet Aypak, Esragül Akıncı, Selma Karahmetoğlu, Emin Gemcioglu, Emra Kalkan, Osman İnan, Abdulrezzak Yilmaz, Bagdagul Güler, Esra Çopuroğlu, İşil Turan, Derya Gökmen, Serhat Hayme, Aziz Ahmet Surel
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
BackgroundThe aim of the study is to assess the effect of chronic lung disease on mortality in patients hospitalized with the diagnosis of prevariant COVID-19 Pneumonia compared to patients without chronic lung disease.Research design and methodsA co
Externí odkaz:
https://doaj.org/article/f1e64985467c4a5bbaf6b36186be32b3
Autor:
Rahmet Guner, Imran Hasanoglu, Bircan Kayaaslan, Adalet Aypak, Esragul Akinci, Hurrem Bodur, Fatma Eser, Ayse Kaya Kalem, Orhan Kucuksahin, Ihsan Ates, Aliye Bastug, Yasemin Tezer Tekce, Zeynep Bilgic, Fahriye Melis Gursoy, Hatice Nisa Akca, Seval Izdes, Deniz Erdem, Emra Asfuroglu, Habibe Hezer, Hatice Kilic, Musa Civak, Sibel Aydogan, Turan Buzgan
Publikováno v:
Journal of Infection and Public Health, Vol 15, Iss 1, Pp 65-67 (2022)
Externí odkaz:
https://doaj.org/article/3a7a1bf4021b4813b2a7510ec6444748
Autor:
Rahmet Guner, Imran Hasanoglu, Bircan Kayaaslan, Adalet Aypak, Esragul Akinci, Hurrem Bodur, Fatma Eser, Ayse Kaya Kalem, Orhan Kucuksahin, Ihsan Ates, Aliye Bastug, Yasemin Tezer Tekce, Zeynep Bilgic, Fahriye Melis Gursoy, Hatice Nisa Akca, Seval Izdes, Deniz Erdem, Emra Asfuroglu, Habibe Hezer, Hatice Kilic, Musa Cıvak, Sibel Aydogan, Turan Buzgan
Publikováno v:
Journal of Infection and Public Health, Vol 14, Iss 3, Pp 365-370 (2021)
Background: In this study, we aimed to compare the intensive care unit (ICU) admission rate of hospitalized mild/moderate COVID-19 patients treated with hydroxychloroquine (HCQ), favipiravir, and HCQ plus favipiravir. Methods: Single center retrospec
Externí odkaz:
https://doaj.org/article/da902bb1ba0845cc85ea0e9fdd987927